TGM2 and celiac disease: Of note, although it was reported that TGM2 activation was associated with the development of cancer,[31] celiac disease[32] and neurodegenerative diseases,[33] no obvious tumors, diarrhea, and cognitive behavioral impairments were found in mice during FSK administration.